Search PubMed⌕ Search

Biomedical subjects

A Otto

Publications and source records attributed to A Otto.

At least 127 records · Page 7Linked to original sources
PubMed1988

A 13-kilodalton protein purified from milk fat globule membranes is closely related to a mammary-derived growth inhibitor.

With the use of specific antibodies against a previously purified [Boehmer, F.-D., Lehmann, W., Schmidt, H., Lange, P., & Grosse, R. (1984) Exp. Cell Res. 150, 466-477] and sequenced mammary-derived growth inhibitor (MDGI) [Boehmer, F.-D., Kraft, R., Otto, A., Wernstedt, C., Hellmann, U., Kurtz, A., Mueller, T., Rohde, K., Etzold, G., Lehmann, W., Langen, P., Heldin, C.-H., & Grosse, R. (1987) J. Biol. Chem. 262, 15137-15143], the localization and relative amount of immunoreactive 13-kilodalton (kDa) antigen in different fractions of bovine milk were determined. The highest amount of antigen was found to be associated with the milk fat globule membranes (MFGM). As revealed by a dot immunobinding assay, the amount of immunoreactive bovine and human MFGM-associated antigen increased dramatically with the onset of lactation after delivery. This finding corresponds to earlier data obtained for MDGI and indicates a relationship between the proliferative state of mammary epithelial cells and the amount of immunoreactive antigen. The 13-kDa antigen has been purified from MFGM to homogeneity by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electroelution. The MFGM-derived 13-kDa polypeptide was found to be almost identical with MDGI as demonstrated by tryptic digestion and partial amino acid sequence analysis of tryptic fragments of both proteins. The results clearly show the presence of a membrane-bound MDGI-related 13-kDa protein, thus supporting the possible involvement of membrane-associated growth inhibitors in growth regulation of mammary epithelial cells.

Amino Acid Sequence↗
PubMed1988

Electrostatic interactions between cytochrome P-450 LM2 and NADPH-cytochrome P-450 reductase.

At pH 8.2 and a 100-fold molar excess of the amino group specific label 2-methoxy-5-nitrotropone (MNT) over protein 2 mol MNT/mol P-450 LM2 were bound, which caused a 50% decrease in the overall activity due to a decreased electron transfer rate from reductase to the hemoprotein. However, different from FITC modification, which produces the same effects, the label is not selectively bound to the alpha-amino group and to lysine 384, but reacts with lysines in positions 49, 100, 139, 144, 251, 384 and 433. The decrease in the overall activity and reduction rate thereby correlates with a relative increase in the modification of lysines 139, 144, 251 and 384. Thus, besides lysine 384 the epsilon-amino groups of lysines 139, 144 and 251 are further candidates for participation in the interaction with reductase. This finding supports our model of charge-pair contacts between P-450 and reductase, where amino groups of P-450 LM2 form salt bridges to carboxylic groups of reductase. The decrease of reductase supported P-450 reduction velocity in microsomes at high salt concentration (I greater than 222 mM) indicates the dominant electrostatic character of P-450/reductase interaction. Based on these results and data from the literature a model of membrane topography of P-450 LM2 has been proposed. Extension of the charge pair interaction model to interaction mechanisms of other P-450 isoenzymes and forms with their respective electron donors is discussed.

Amino Acid Sequence↗
PubMed1988

Purification of the growth-related protein p25 of the Ehrlich ascites tumor and analysis of its isoforms.

1. Two of the three isoforms of the growth-related protein p25 of the Ehrlich ascites tumor have been purified to homogeneity by giant two-dimensional polyacrylamide gel electrophoresis. 2. Antibodies raised against the isoform p25/1 react also with isoforms p25/2 and p25/3. 3. Limited tryptic digestion of p25/1 and p25/2 resulted in similar oligopeptide patterns. Corresponding oligopeptides of both isoforms have identical amino acid sequences. 4. The isoforms p25/2 and p25/3 are phosphorylated derivatives of unphosphorylated p25/1. The phosphorus is bound to serine and a further unknown phosphorylation site.

Amino Acid Sequence↗
PubMed1987

Identification of a polypeptide growth inhibitor from bovine mammary gland. Sequence homology to fatty acid- and retinoid-binding proteins.

A polypeptide growth inhibitor purified from bovine mammary gland (mammary-derived growth inhibitor) has been shown to reversibly inhibit proliferation of mammary carcinoma cells at concentrations of about 10(-10) M. The carrier of inhibitory activity has been identified biochemically as an about 13-kDa polypeptide and chemically by elucidating the amino acid sequence. No homology to any of the hitherto structurally investigated growth inhibitors (transforming growth factor beta, interferons) has been observed. The data revealed extensive sequence homology of mammary-derived growth inhibitor to a family of low molecular mass hydrophobic ligand-binding proteins, among them a fatty acid-binding protein from rat heart, myelin P2, a differentiation associated protein in adipocytes (p422) and the cellular retinoic acid-binding protein. Interaction with as yet unknown hydrophobic ligands might play a functional role in the mechanism of growth inhibition excerted by mammary-derived growth inhibitor.

Animals↗
PubMed1987

Fructose-2,6-bisphosphatase and 6-phosphofructo-2-kinase are separable in yeast.

Fructose-2,6-bisphosphatase was purified from yeast and separated from 6-phosphofructo-2-kinase and alkaline phosphatase. The enzyme released Pi from the 2-position of fructose 2,6-bisphosphate and formed fructose 6-phosphate in stoichiometric amounts. The enzyme displays hyperbolic kinetics towards fructose 2,6-bisphosphate, with a Km value of 0.3 microM. It is strongly inhibited by fructose 6-phosphate. The inhibition is counteracted by L-glycerol 3-phosphate. Phosphorylation of the enzyme by cyclic-AMP-dependent protein kinase causes inactivation, which is reversible by the action of protein phosphatase 2A.

Chromatography, Affinity↗
PubMed1986

Kinetic effects of fructose-1,6-bisphosphate on yeast phosphofructokinase.

Yeast phosphofructokinase is known to be effectively activated by fructose-2,6-bisphosphate and AMP. In the absence of the two effectors, fructose-1,6-bisphosphate activates or inhibits the enzyme according to the concentrations of the substrates and of inorganic phosphate. At cellular concentrations of the substrates, however, the effects of fructose-1,6-bisphosphate are negligible. Whereas the activation of the enzyme by AMP is not affected by fructose-1,6-bisphosphate, the latter was found to diminish strongly the activity of the fructose-2,6-bisphosphate-activated enzyme. Inorganic phosphate amplifies the activating effect of fructose-2,6-bisphosphate and augments also the deactivation of the fructose-2,6-bisphosphate-activated enzyme. The deactivating action of fructose-1,6-bisphosphate with respect to fructose-2,6-bisphosphate dominates at low concentrations of fructose-6-phosphate and high levels of ATP and might be of regulatory significance.

Enzyme Activation↗
PubMed1985

Effects of fructose 1,6-bisphosphate on the activation of yeast phosphofructokinase by fructose 2,6-bisphosphate and AMP.

Fructose 1,6-bisphosphate decreases the activation of yeast 6-phosphofructokinase (ATP:fructose 6-phosphate 1-phosphotransferase, EC 2.7.1.11) by fructose 2,6-bisphosphate, especially at cellular substrate concentrations. AMP activation of the enzyme is not influenced by fructose 1,6-bisphosphate. Inorganic phosphate increases the activation by fructose 2,6-bisphosphate and augments the deactivation of the fructose 2,6-bisphosphate activated enzyme by fructose 1,6-bisphosphate. Because various states of yeast glucose metabolism differ in the levels of the two fructose bisphosphates, the observed interactions might be of regulatory significance.

Adenosine Monophosphate↗
PubMed1985

Interaction of ADP and fructose-2,6-bisphosphate with phosphofructokinase-1 from yeast.

ADP was found to activate or, depending on the experimental conditions, to inhibit yeast phosphofructokinase-1. In the absence of AMP and fructose-2,6-bisphosphate ADP increases the apparent affinity of the enzyme to fructose-6-phosphate. At low ATP concentrations the maximum activity with respect to fructose-6-phosphate decreases in the presence of ADP, while at high ATP a significant increase of the maximum activity by ADP is observed. In the presence of fructose-2,6-bisphosphate and AMP only the inhibiting effect of ADP persists. The data may be interpreted in terms of a hyperbolic inhibition mechanism.

Adenosine Diphosphate↗
PubMed1984

First-pass determination of the right ventricular ejection fraction using two regions of interest and the right anterior oblique view.

The right ventricular ejection fraction (RVEF) was determined on the right anterior oblique view in 9 patients during the first pass of a bolus of technetium-99m employing a gamma camera with high count-rate capability. The RVEF was calculated by using: (i) a fixed end-diastolic region of interest (ROI); and (ii) an end-diastolic and end-systolic ROI. Because of the movement of the tricuspid plane the first of these methods often gave low values, and agreement between the first two peaks was not as good as that when the second method was used. The mean for the second method was in agreement with that in a previous study using a gated first-pass technique and two ROIs but was somewhat higher than those reported by workers using either one ROI or the anterior view.

Cardiac Output↗
PubMed1984

Cooperation of fructose-2,6-bisphosphate and AMP in the activation of yeast phosphofructokinase.

Yeast phosphofructokinase is effectively activated by AMP and fructose-2,6-bisphosphate. Both effectors influence the sensitivity of the enzyme with respect to fructose-6-phosphate and increase the respective maximum activities. The dependence of phosphofructokinase activity on the concentration of fructose-2,6-bisphosphate was measured at different AMP concentrations and vice versa. By AMP the half activation constant for fructose-2,6-bisphosphate is decreased by one order of magnitude. The affinity to AMP is significantly increased by fructose-2,6-bisphosphate. AMP increases the maximum activity of the enzyme with respect to fructose-2,6-bisphosphate only slightly, while the maximum activity with respect to AMP is drastically increased by fructose-2,6-bisphosphate. The interaction of the two activators is most pronounced at low levels of fructose-6-phosphate and at high concentrations of ATP.

Adenosine Monophosphate↗
PubMed1983

Similarity of activation of yeast phosphofructokinase by AMP and fructose-2,6-bisphosphate.

Phosphofructokinase from yeast is effectively activated by AMP and fructose-2,6-bisphosphate by increasing the affinity of the enzyme to fructose-6-phosphate and the maximum activity toward this substrate. The enzyme is activated by AMP and fructose-2, 6-bisphosphate both at high and at low concentrations of ATP. The half maximum stimulation concentrations of AMP and fructose-2, 6-bisphosphate are about 200 microM and 2 microM, respectively. At saturating concentrations of AMP and fructose-2, 6-bisphosphate similar maximum activities were observed in the dependence of enzyme activity on the concentrations of fructose-6-phosphate. The fructose-6-phosphate affinity is more enhanced by fructose-2, 6-bisphosphate than by AMP.

Adenosine Monophosphate↗
PubMed1975

Synthesis of substituted 5-fluoro-5,6-dihydropyrimidines.

The reaction of 5-substituted uracils with fluorine in acetic acid and other solvents and the following treatment with different alcohols yielded the corresponding 5-fluoro-5,6-substituted-5,6-dihydropyrimidines. Thymine gave 5-fluoro-5-methyl-6-alkoxy-5,6-dihydropyrimidines. 5-Halogeno uracils and 5-nitrol uracil were converted into 5-fluoro-5-halogeno-6-hydroxy-5,6-dihydropyramidines and the 5-nitroanalogue, respectively. The structures of the compounds were confirmed by mass spectrometry.

Fluorine↗